Female Hormone Health, Fertility & Vitality
Summary
Dr. Natalie Crawford, a double board-certified OB/GYN and reproductive endocrinologist, provides a comprehensive masterclass on female hormones, fertility, and reproductive health. The conversation spans from fetal egg development through puberty, the menstrual cycle, birth control, IVF, and nutrition — dismantling common misconceptions along the way. Key emphasis is placed on the menstrual cycle as a vital sign and the importance of understanding hormonal communication between the brain and ovaries.
Key Takeaways
- Egg freezing does not deplete your future egg supply — eggs are lost from the ovarian “vault” continuously regardless of IVF, birth control, or pregnancy; the procedure only captures eggs that would have been lost anyway.
- The menstrual cycle is a vital sign — irregular cycles or a sudden shortening of cycle length (e.g., from 28 days to 24 days) can signal declining ovarian reserve and warrants evaluation.
- Birth control pills do not cause infertility, but they can suppress AMH (anti-Müllerian hormone) by up to 30%, potentially masking true ovarian reserve if tested while on the pill.
- The fertile window is approximately 5 days, ending on the day of ovulation; the egg survives only 24 hours, while sperm can survive up to 5 days.
- Smoking cigarettes directly reduces egg quantity and quality, accelerates entry into menopause, and increases chromosomal abnormalities. Vaping is similarly associated with poor IVF outcomes.
- Cannabis impairs sperm motility, morphology, and DNA integrity; paternal cannabis use is associated with higher miscarriage rates.
- Alcohol should be zero during pregnancy and kept to 1–2 drinks per week when trying to conceive, as chronic use causes inflammation that degrades egg and sperm quality.
- Endocrine-disrupting chemicals — including lavender, tea tree oil, and synthetic fragrances — can trigger premature secondary sex characteristics in children; consistent daily exposure is more concerning than occasional contact.
- PCOS involves unopposed estrogen due to lack of ovulation, significantly raising endometrial cancer risk; oral contraceptives reduce this risk and dramatically reduce ovarian cancer risk with 10+ years of use.
- The Depo-Provera shot can suppress ovulation for up to 18 months after the last injection; discontinue 1.5–2 years before attempting pregnancy.
Detailed Notes
Egg Development & Ovarian Reserve
- At 20 weeks gestation, a female fetus has approximately 6–7 million eggs — the lifetime maximum.
- By birth, more than half are already gone. Egg loss is continuous and irreversible, occurring every month regardless of ovulation, birth control, or pregnancy.
- Eggs are housed in follicles within the ovarian vault. Each month, a cohort of follicles is released; those that don’t ovulate simply die.
- AMH (anti-Müllerian hormone) is produced by granulosa cells surrounding each follicle. Higher egg count = more follicles released monthly = higher AMH. It is the primary clinical marker of ovarian reserve.
- AMH can be suppressed up to 30% by oral contraceptive use. If a low AMH result is obtained while on the pill, discontinue contraception, switch methods, and retest after several months before drawing conclusions.
Puberty Timing & Fertility
- Thelarche (breast budding) occurs approximately 2 years before menarche (first period).
- Adrenarche (pubic and axillary hair development) typically coincides with or slightly precedes breast budding.
- Average age of menarche has shifted from 13–15 years (10–20 years ago) to 10–11 years in the U.S., likely driven in part by endocrine-disrupting chemical exposure.
- Earlier puberty does NOT shorten the reproductive lifespan — egg loss begins in fetal development regardless of when puberty starts.
- Earlier puberty does correlate with reduced final adult height, as high estrogen closes growth plates around the time of first menstruation.
The Menstrual Cycle
- Cycle Day 1 = first day of bleeding (even spotting counts).
- Follicular phase: FSH stimulates follicle growth → follicle produces estradiol → uterine lining thickens → rising estrogen improves mood, energy, and libido.
- Ovulation trigger: Estradiol must reach ~200 pg/mL for ~50 hours to signal the brain to release an LH surge, causing the dominant follicle (a fluid-filled cyst) to rupture and release the egg.
- Luteal phase: The ruptured follicle becomes the corpus luteum, which produces progesterone for 12–14 days. Progesterone stabilizes the uterine lining for potential implantation.
- If no pregnancy occurs, the corpus luteum dies, estrogen and progesterone drop, and bleeding begins.
- The luteal phase is fixed at ~12–14 days; variability in cycle length comes from the follicular phase.
- Normal cycle range: 21–35 days, but more importantly, cycles should be predictable and consistent for the individual.
- A sudden shortening of cycle length (e.g., always 28–30 days now becoming 24 days) is a red flag for declining ovarian reserve — fewer eggs mean the dominant follicle matures faster.
- Mittelschmerz: Ovulatory pain felt mid-cycle in some women, caused by the rupture of the follicular cyst and release of follicular fluid into the pelvic cavity.
Fertility & Conception Timing
- Fertile window: ~5 days ending on the day of ovulation.
- Egg survives 24 hours post-ovulation; sperm survive up to 5 days in the reproductive tract.
- Top fertility days: Day before and day of ovulation.
- Daily intercourse is associated with highest conception rates but can cause stress and “sexual burnout.” Every other day throughout the fertile window is a practical alternative.
- Saving sperm for 2–3 days does NOT increase conception odds naturally; abstinence protocols for semen analysis and IUI/IVF are based on standardized testing parameters, not optimization of natural conception.
Birth Control
Combined Oral Contraceptive Pill (Estrogen + Progestin)
- Contains ethinyl estradiol (not the same as the body’s own estradiol) and a synthetic progestin.
- Does not deplete the egg vault — eggs are released from the vault monthly but die without FSH stimulation.
- Suppresses AMH in some users; reversible upon discontinuation.
- Reduces ovarian cancer risk by >90% with 10+ years of use.
- Significantly reduces endometrial cancer risk.
- Possible risks: increased blood clots (especially with Factor V Leiden mutation), vaginal/vulvar atrophy with continuous use, potential gut microbiome disruption (leaky gut, IBS), masking of hormonal irregularities.
- Some women experience improved mood stability (especially with PMDD); others may experience mood changes with estrogen fluctuations.
Copper IUD
- Non-hormonal; creates a toxic, inflammatory environment lethal to sperm.
- Ovulation proceeds normally; periods may be heavier but should remain regular.
- Irregular periods on a copper IUD suggest a separate hormonal issue.
Hormonal IUD (Mirena, Kyleena, Liletta)
- Releases local progestin, thinning the uterine lining.
- ~50% of users continue to ovulate; main mechanism is endometrial suppression.
- Long-term use (5–7 years) can cause significant endometrial atrophy, leading to absent periods (amenorrhea) even in ovulating women.
- After removal, it may take several months for the lining to recover and regular periods to resume.
- Recommendation: Remove 3–6 months before attempting pregnancy to ensure lining recovery.
Depo-Provera (Progesterone Injection)
- High-dose progestin;